---
title: "MyRacehorse Review 2026: Three Exemptions, One Storefront, and Fees Plus Reserve Near Half the Raise"
url: https://altstreet.investments/platforms/reviews/myracehorse
kind: platform-review
updated: 2026-11-11
description: "MyRacehorse review: the Form 1-A Use of Proceeds tables show fees, expenses and operating reserve of 47.82% to 59.92% of each raise, a brokerage fee that rose from 1% to 5% in 2025, and eight consecutive loss years totaling $40.2 million."
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# MyRacehorse Review 2026: Three Exemptions, One Storefront, and Fees Plus Reserve Near Half the Raise

Fractional thoroughbred ownership sold to retail investors under three exemptions at once, where the offering circulars show roughly half of every dollar raised going to fees, expenses and reserve before the horse runs, and the Manager taking 20% of gross sale proceeds when the horse appreciates, or 5% when it does not.

AltStreet score: 28.6 (D-), scored September 27, 2026. Method: https://altstreet.investments/platforms

| Field | Value |
| --- | --- |
| Platform | MyRacehorse |
| What it is | Retail fractional racehorse platform (Nevada series LLC under Regulation A Tier 2, alongside a Regulation Crowdfunding issuer and single-horse Rule 506(c) LLCs, with separate US, Australian and UK marketplaces) |
| Asset class | Thoroughbred racehorses, held as membership interests in a series of a series LLC; returns come from purse money and from a share of any sale, stud or broodmare value |
| Website | myracehorse.com |
| Review first published | September 27, 2026 |
| Last updated | November 11, 2026 |
| AltStreet relationship | None: no affiliate, sponsorship or partnership |

## The short version

A Regulation A series LLC that has sold interests in more than 180 horses across three countries, has lost money in every one of its eight reported years, and whose own offering circulars show that between 40% and 52% of each raise buys the horse while the balance goes to fees, reserve and discount.

- **47.8% TO 59.9%** The Total Fees and Expenses line as a share of gross proceeds across the ten series with a Use of Proceeds table in the September 2026 circular, median 56.49%. It includes the operating expense reserve for the horse's care; the fee lines outside it are 21.00% to 32.50%.
- **TWO FEES UP** On the 2025 series the brokerage fee went from 1.00% to 5.00% of the raise and the Manager's Bloodstock Fee from 5.00% to 7.50% of the horse cost. Neither change is explained.
- **3.08x TO BREAK EVEN** Median sale multiple on the horse's acquisition value needed to return the whole raise from the sale alone, treating the operating reserve as spent, across the 12 series with both figures filed. Range 2.58x to 3.33x.
- **$4.88 MILLION** Manager compensation for fiscal 2025 to Experiential Squared, Inc., being $4,163,728 in cash and $716,943 in other compensation.
- **20% OF THE SALE** The Final Gross Proceeds Fee on every series AltStreet read: 20% of gross sale proceeds if the horse appreciated, 5% if it did not, before any deductions. It is not in the Use of Proceeds table.

Data note: Offering economics are from the Form 1-A Use of Proceeds tables under file 024-12611. Financial history is from the Form 1-K annual reports; net losses for fiscal 2023 to 2025 are taken from each year's going-concern note. Horse counts and prices are the platform's own API output captured 2026-09-27.


## Verdict

The disclosure is genuine and the deductions from each raise are genuinely heavy. MyRacehorse files audited annual reports, itemizes its Use of Proceeds series by series, states the interest it acquired in each animal, names its broker of record and discloses its Manager's compensation. Read those documents and you find a structure where roughly half of each raise goes to fees and to a reserve for the horse's care rather than to the horse, where the Manager then takes 20% of the gross proceeds of the sale, and where the Regulation A issuer has lost money in all eight of its reported years. Put the front end and the exit together and the horse has to sell for a median 3.08 times its acquisition value before the sale alone returns an investor's capital. The experience being sold is real. The economics are what they are, and they are disclosed, though the largest single term is not in the table that totals the fees.

**Best for**

- Racing fans who want the owner-style membership experience, winners circle access included, and would otherwise pay for hospitality anyway
- People who understand that a single racehorse can be worth nothing and are sizing the position accordingly
- Anyone who will actually read the Use of Proceeds table for the specific horse before subscribing

**Look elsewhere if**

- You need to be able to sell. There is no secondary market and no redemption right
- You are comparing this to a fund on fees. A median 56.49% of the raise going to fees, expenses and reserve is a different category of transaction, not a wider spread
- You are treating the horse value on the listing as a valuation. It is the platform's own figure and the offering price implies a different number

**Strengths**

- Use of Proceeds is itemized per series, showing Asset Cost, each front-end fee line and the operating expense reserve as both dollars and a percentage of gross proceeds
- The circular states the percentage interest the series actually acquired in the horse, so a 51% or 70% interest is visible rather than implied
- Audited annual reports every year since 2018, with a consolidating schedule that breaks out every series
- Compensated spokespersons are covered by a written policy requiring disclosure of amount, source and type of compensation, prior approval of promotional content and takedown rights, with individual Rule 17(b) disclosure pages
- No enforcement action against the issuer, the Manager or any affiliate in AltStreet's scan, and the filings state no material legal proceedings

**Limitations**

- A Total Fees and Expenses line of 47.82% to 59.92% of gross proceeds across the series read, median 56.49%, of which the operating expense reserve for the horse's care is 15.32% to 33.93% and the fee lines 21.00% to 32.50%; that line is the front end only
- A Final Gross Proceeds Fee on every series read, being 20% of gross sale proceeds where the horse appreciated and 5% where it did not, plus 10% of gross stakes-race prize money, none of which appears in the Use of Proceeds table
- Taken together the horse must sell for 2.58 to 3.33 times its acquisition value, median 3.08 times, before the sale alone returns capital, treating the operating reserve as spent
- A Bloodstock Fee of up to 7.5% to the Manager sits inside the Asset Cost line rather than beside it, so the asset figure overstates what reaches the animal
- Two fees rose on the 2025 series with no explanation in the circular: brokerage from 1.00% to 5.00% of the raise, and the Manager's Bloodstock Fee from 5.00% to 7.50% of the horse cost
- Eight consecutive loss years totaling $40,165,621, against Manager compensation of $4,882,671 in fiscal 2025 alone
- No secondary market and no redemption right, in an asset whose value can go to nothing without warning
- Dalmore Group, LLC, the broker of record on the Reg A offerings, carries two FINRA disciplinary actions, in March 2021 and September 2024


## What this means for your decision.

| Topic | Finding |
| --- | --- |
|  | About half of what you pay does not buy horse |
|  | Two fees went up on the 2025 series, one of them fivefold |
|  | The Manager also takes 20% of the sale, and that is not in the fee table |
|  | Sometimes you are buying part of a horse, not a horse |
|  | Eight straight years of losses, about $40.2 million in total |

The disclosure is genuine and the deductions from each raise are genuinely heavy, and both facts come out of the same document. If you are buying an ownership experience with a lottery ticket attached, the product is coherent. If you are buying an investment, the Use of Proceeds table for your specific horse is the first thing to read and probably the last thing you need.


## Who it fits

| Investor | Fit | Why |
| --- | --- | --- |
| Racing fans buying the ownership experience | moderate |  |
| Speculators sizing a position they can lose entirely | moderate |  |
| Investors seeking a measurable return record | poor-fit |  |
| Anyone who may need their money back | poor-fit |  |


## Not for

- Anyone who needs to get their money out on a timetable. There is no secondary market and no redemption right.
- Anyone comparing this to an index fund on fees. A median 56.49% of the raise to fees, expenses and reserve, plus 20% of the gross sale proceeds at the end, against a 0.03% index fund is not a spread, it is a different category of transaction.
- Anyone who reads the Use of Proceeds table and stops there. The largest single term, a 20% cut of gross sale proceeds, is in the paragraph underneath it.
- Anyone relying on the horse value shown on the platform as a valuation. It is the platform's own figure, and the offering price implies a different number.
- Anyone who would need the position to work out. Of the 118 horses in the US stable feed, 59 are retired and 29 never raced.


## Questions

**Is MyRacehorse legit?**

AltStreet located no SEC or FINRA enforcement action against My Racehorse CA LLC, MRH CF LLC, the Edge Racing entities or Experiential Squared in the sources reviewed, and the annual reports state no material legal proceedings. The company files audited annual reports and has been continuously qualified under Regulation A since 2018. Note that qualification under Regulation A is not SEC approval of an offering or of its merits. The concerns here are economic rather than about legitimacy: fees, expenses and the operating reserve for the horse's care take 47.82% to 59.92% of each raise across the series reviewed, there is no secondary market or redemption right, and the issuer has reported a net loss in every one of its eight reported years.

**How much of my money actually buys the horse?**

Between 40.08% and 52.18% across the ten series AltStreet read in the current offering circular. The Asset Cost line also includes a Bloodstock Fee paid to the Manager, 5.00% or 7.50% of the horse cost depending on the series, and any applicable sales or use tax, so the share reaching the animal is lower than the Asset Cost percentage suggests. The remainder is a 15% Management and Due Diligence Fee, an Organizational and Experiential Fee of up to 12.5%, a brokerage fee of 1% or 5% depending on the series, and an operating expense reserve funding roughly two years of training and care. Separately, and not shown in that table, the Manager takes 20% of the gross proceeds when the horse is sold, or 5% if the horse lost value.

**Can I sell my MyRacehorse shares?**

No. There is no secondary market and no redemption right. The holding period ends when the Manager sells the horse or the horse is retired or dies. The offering materials describe the investment as speculative and illiquid with possible loss of the entire investment.

**How much does the horse have to sell for before I get my money back?**

From the sale alone, between 2.58 and 3.33 times what the horse cost, median 3.08 times, across the 12 series with both a filed raise and a stated horse cost. Two things drive it: fees, expenses and the operating reserve take a median 56.49% of the raise, and the Manager's Final Gross Proceeds Fee then takes 20% of the gross sale proceeds where the horse appreciated. Without that exit fee the median would be 2.47 times. The calculation treats the reserve as spent on the horse's care; any unused reserve that is distributed lowers it, to about 2.1 to 2.4 times if the reserve were returned in full. Prize money distributed while the horse races reduces what the sale has to do, and the series repays any expenses the Manager advanced, with interest at no less than the Applicable Federal Rate, before it distributes.

**What do I actually get if the horse wins?**

Purse money net of costs can be distributed in proportion to your interest in the series, and you share in any sale, stud or broodmare value on the same basis, after the Manager takes 10% of gross proceeds from stakes races and 20% of gross proceeds on a sale where the horse appreciated. The Manager has sole discretion over whether and when any distribution is made and in what amount. Note that your block buys a percentage of the series, and six of the series AltStreet read own only part of the horse: Marsh Hawk 24 acquired a 75% interest, Thatcher 25 and Tail Feather 24 a 70% interest each, and Ali Blue 24, Eyepopnruby 23 and Just Like Lucy 23 a 51% interest each.

**Why are there different rules on different horses?**

The US book runs three exemptions at once. Most horses are offered by My Racehorse CA LLC under Regulation A, some by MRH CF, LLC under Regulation Crowdfunding, and some by single-horse Edge Racing LLCs under Rule 506(c), which is open only to accredited investors. Of the 14 US offerings open on 2026-09-27, nine were Reg A, four were Reg CF and one was 506(c). The jurisdiction is shown on each listing.

**Has MyRacehorse ever made a profit?**

Not in any year it has reported. My Racehorse CA LLC recorded net losses in each fiscal year from 2018 to 2025, totaling $40,165,621. The annual reports describe the issuer as a development stage company and say series revenue does not begin until a horse races in its two-year-old season, while training, care, veterinary and depreciation costs begin at acquisition.

**What are MyRacehorse's fees?**

Per the current offering circular: a Management and Due Diligence Fee of 15% of gross cash proceeds; an Organizational and Experiential Fee of up to 12.5%, being 12.50% on eight of the ten series that state a figure, 10.00% on one and 5.00% on one; a Brokerage and Payment Processing Fee of 1.00% on the 2023 and 2024 series and 5.00% on the 2025 series; a Bloodstock Fee to the Manager counted inside the Asset Cost line, at 5.00% of the horse cost on the 2023 and 2024 series and 7.50% on the 2025 ones; and an Operating Expense Reserve of 15.32% to 33.93% that funds roughly two years of training, boarding, veterinary care and transport. Across the ten series AltStreet read, the Total Fees and Expenses line comes to 47.82% to 59.92% of gross proceeds, median 56.49%. That line includes the operating expense reserve; the fee lines outside it come to 21.00% to 32.50%, median 28.50%.

**How do I check the numbers on a specific horse myself?**

Search EDGAR for CIK 1744448 and open the most recent Form 1-A post-qualification amendment under file 024-12611. Each series has a Use of Proceeds section that names the series, states gross proceeds, and lists Asset Cost and every fee in both dollars and percentages, with a Total Fees and Expenses line. The narrative under each table states the percentage interest the series acquired in the animal, what the horse cost, the Bloodstock Fee, any use tax and any Original Issue Discount. Note that the series is named for the dam and foaling year, such as Storm Raven 24, while the platform shows the horse's racing name once it has one.


## Update history

**November 11, 2026: Four horses sold at Keeneland, three series to be wound up, and three new series in the November 10 circular**

A Form 1-U filed November 10, 2026 (accession 0001683168-26-008487) reports four horses sold at the Keeneland November Breeding Stock Sale between November 5 and 8: Madame Secretary for $710,000, of which Series Incredi-Bundle owned 51%; Community Adjusted for $150,000 and Tiffany's Mo for $100,000, of which Series STG Broodmare Band owned 100% and 60%; and Isle Blue for $70,000, owned 100% by Series Blue Curl 22, which bought the last 49% for $14,700 on her retirement in December 2025. The Manager will distribute each series' remaining cash after unused insurance and reserves, less 'related fees, liabilities, and expenses, including but not limited to a due diligence fee, management fee, offering expenses, and if any, owed to the Manager', within 90 days, and then wind the three series up. The filing states no distribution amount and does not mention the Final Gross Proceeds Fee. The series' ownership shares of the auction prices are $362,100, $210,000 and $70,000 (AltStreet's arithmetic), $642,200 in all before deductions, against $2,689,700 raised per the fiscal 2025 Form 1-K; this measures the series' share of gross prices, not a payout. The amended fiscal 2025 report (Form 1-K/A No. 2, filed September 2, 2026, accession 0001683168-26-006867) records for 2025 $187,084 of proceeds from horse dispositions and $81,700 of distributions in STG Broodmare Band, a table that does not identify the horses, and $22,440 of distributions in Incredi-Bundle; the first-half 2026 report records none for the three series. The fiscal 2025 report lists seven horses in STG Broodmare Band, the 1-U describes the sale of two mares and says the remaining assets are only cash, and the filings do not say what became of the other five or whether proceeds from them remain in the series. The offering circular filed the same day under Rule 253(g)(2) (accession 0001683168-26-008488) adds Cara Marie 25, Killdress Kay 25 and Lucky Draw 25, with total fees and expenses of 57.91%, 62.67% and 56.18%; the October 15, 2026 circular had added Surfer's Paradise 25 at 57.36%. All four carry 5.00% brokerage, a 7.50% Bloodstock Fee and the Final Gross Proceeds Fee; Killdress Kay 25's operating reserve alone is 30.17% of its proposed raise. The fee-load and break-even statements now state that the Total Fees and Expenses line includes the operating expense reserve (15.32% to 33.93% on the ten series; fee lines outside it 21.00% to 32.50%), that the reserve funds the horse's care and any overage can become Distributable Cash, and that the 3.08x median treats the reserve as spent, with about 2.1x to 2.4x if it were returned in full.

**October 2, 2026: First-half 2026 semiannual report: revenue $500,998, net loss $4,382,604, management fees $1,797,916, going-concern doubt restated**

The Form 1-SA filed September 30, 2026 (accession 0001683168-26-007505) for the six months to June 30, 2026 reports revenue of $500,998 against $1,597,655 a year earlier, when Series Straight No Chaser alone earned $1,214,965; costs of revenue of $1,118,844 against $1,555,319; operating expenses of $3,764,758 against $2,080,804, of which management fees to Experiential Squared were $1,797,916 and depreciation $1,880,103, with the prior period also carrying a $1,052,279 gain on horse retirements against $122,364; and a net loss across all series of $4,382,604 against $2,029,683. The consolidated balance sheet shows total assets of $9,750,670 (horse assets $6,288,645 net, reserve funds held by the Manager $3,449,357), liabilities of $1,643,734 (acquisition advances payable to the Manager $1,491,008) and members' equity of $8,106,936, up from $6,370,823 at December 31, 2025 on new subscriptions. Note 3 repeats that the company and each series has not generated profits since inception, is dependent on the Manager for financing, and that these factors raise substantial doubt about going concern. Seventeen horses in offered series had not yet raced at June 30. The figures are in the platform's performance history; the review's fee and outcome findings are unchanged by the report.

**September 27, 2026: Correction: the review missed a 20% cut of gross sale proceeds, and understated the break-even**

The first version of this review, published earlier the same day, described the fee load using the Use of Proceeds table and said an investor needed the horse to roughly double in value. Both were incomplete. Every series described in every circular AltStreet read also carries a Final Gross Proceeds Fee, being 20% of Final Sale Gross Proceeds where the horse appreciated and 5% where it depreciated, charged on all money generated by the sale prior to any deductions, plus a Management Performance Bonus of 10% of gross proceeds from stakes races. Neither appears in any Use of Proceeds table. Correcting for them, the break-even sale multiple is 2.58 to 3.33 times the horse's acquisition value, median 3.08 times, against 2.47 times without the exit fee, and against the roughly 2 times first published. The stated expected hold was also corrected: the Company estimates most series will exist 2 to 6 years, which the first version reported as no stated exit date.

**September 27, 2026: Initial review: three exemptions behind one storefront, and a filed fee load near half the raise**

Built from the platform's own API and from the Form 1-A circulars. The central finding is the Use of Proceeds table, which itemizes a fee load of 47.82% to 59.92% of gross proceeds across the ten series read, median 56.49%, with Asset Cost running 40.08% to 52.18%. Also recorded: two fees that stepped up on the 2025 series with no explanation, brokerage from 1.00% to 5.00% of the raise and the Manager's Bloodstock Fee from 5.00% to 7.50% of the horse cost, the latter counted inside Asset Cost; partial interests of 51% to 75% on six series; eight consecutive loss years totaling $40,165,621; Manager compensation of $4,882,671 in fiscal 2025; and two FINRA disciplinary actions against Dalmore Group, the broker of record.


## Evidence appendix

Platform website captured September 27, 2026.

The horse data is the output of myracehorse.com/api/stable and /api/buylisting for the US, Australian and UK marketplaces, captured 2026-09-27: 182 stable records and 60 buylisting records, of which 30 carried a block price; per marketplace those union to 232 raw records and deduplicate to 202 unique horses. 77 fields per offering record. The offering economics are read from three Form 1-A circulars under offering statement 024-12611, principally Post-Qualification Amendment No. 13 of 2026-09-16, whose Use of Proceeds tables itemize each series in dollars and percentages. Financial history is from the Form 1-K annual reports for fiscal 2018 through 2025. Consolidated net losses for fiscal 2023, 2024 and 2025 are taken from each year's going-concern note, which states the figure in prose, because the consolidating statement of operations prints one column per series and cannot be read by column position; an automated read of that table returned fiscal 2023 net income identical to fiscal 2022, which was the prior-year comparative, and a positional read landed a full year out. Both were discarded. Figures the platform states about itself, including horse values and career earnings, are labeled platform-stated and are not independently verified.

**Highlights**

- Total fees and expenses 47.82% to 59.92% of gross proceeds across ten series, median 56.49%, from the circular's own Total Fees and Expenses line.
- Brokerage and Payment Processing Fee 1.00% on the eight series that state one, 5.00% on both 2025 series.
- Asset Cost 40.08% to 52.18% of gross proceeds, and the Bloodstock Fee of up to 7.5% to the Manager is counted inside it.
- Eight consecutive net loss years 2018 to 2025 totaling $40,165,621, with fiscal 2023 to 2025 read from the going-concern notes.
- Manager compensation $4,882,671 in fiscal 2025; Manager loans to the Company $3,842,776 at 2025-12-31.
- Partial interests acquired on six series: 75%, two at 70% and three at 51%.

**Primary source pages**

- Form 1-A Post-Qualification Amendment No. 13, filed 2026-09-16, accession 0001683168-26-007197, file 024-12611
- Form 1-A Post-Qualification Amendment No. 11, filed 2026-08-31, accession 0001683168-26-006812
- Form 1-A filed 2025-05-02, accession 0001683168-25-003077, linked from the platform's own notices section
- Form 1-K for fiscal 2025, filed 2026-04-27, accession 0001683168-26-003214
- Form 1-K for fiscal 2024, filed 2025-04-28, accession 0001683168-25-002904
- Form 1-K for fiscal 2023, filed 2024-04-29, accession 0001683168-24-002808
- Form 1-A-W filed 2025-05-13, accession 0001683168-25-003484
- myracehorse.com/api/stable and /api/buylisting for the US, AU and UK marketplaces, captured 2026-09-27


## Related

- Full review (HTML): https://altstreet.investments/platforms/reviews/myracehorse
- Every platform review: https://altstreet.investments/platforms/reviews
- Methodology and scoring: https://altstreet.investments/platforms
- Category hub: https://altstreet.investments/platforms

---

Source page: https://altstreet.investments/platforms/reviews/myracehorse
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.
